BCL2 and lymphoma: The decrease of the Bcl-2 protein level after treatment with G3139 asON, which was targeted at the respective gene ́s mRNA, was associated with the suppression of the oncogenic potential of lymphoma cells and a complete blockage of tumor growth in mice [186].